Pathology Research International / 2012 / Article / Tab 4

Review Article

New Evidence-Based Treatment Approach in Behçet's Disease

Table 4

Summary of evidence-based algorithmic treatment for ocular Behçet’s disease.

1st line *Topical: corticosteroids + mydriatics ± cycloplegic agents
Systemic: Corticosteroids, Cyclosporine-A, Azathioprine
2nd lineIFN-α, Anti-TNF-α
3rd lineMethotrexate, Mycophenolate mofetil, Cyclophosphamide, Rituximab

*Topical treatment as a sole agent should be restricted to those who has mild uveitis (anterior uveitis).

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.